WELLS FARGO & COMPANY/MN - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$71,560
-24.9%
7,431
-29.8%
0.00%
Q2 2023$95,256
+118.1%
10,584
+90.5%
0.00%
Q1 2023$43,678
+421.1%
5,557
+348.1%
0.00%
Q4 2022$8,382
-93.7%
1,240
-86.6%
0.00%
Q3 2022$134,000
+42.6%
9,261
-2.8%
0.00%
Q2 2022$94,000
-53.7%
9,528
-30.8%
0.00%
Q1 2022$203,000
-28.5%
13,766
-36.0%
0.00%
Q4 2021$284,000
-79.7%
21,509
-73.2%
0.00%
Q3 2021$1,399,000
-32.4%
80,196
-7.1%
0.00%
Q2 2021$2,068,000
+165.5%
86,307
+184.8%
0.00%
Q1 2021$779,000
+7.3%
30,309
-20.6%
0.00%
Q4 2020$726,000
+15.8%
38,177
-23.3%
0.00%
Q3 2020$627,000
+8.5%
49,781
+4.4%
0.00%
Q2 2020$578,000
+97.9%
47,705
+25.5%
0.00%
Q1 2020$292,000
-62.2%
37,998
-12.3%
0.00%
Q4 2019$773,000
+50.7%
43,351
-2.1%
0.00%
Q3 2019$513,000
-35.1%
44,285
+24.0%
0.00%
Q2 2019$791,000
-20.1%
35,710
+3.2%
0.00%
Q1 2019$990,000
+45.2%
34,607
+0.3%
0.00%
Q4 2018$682,000
+14.0%
34,519
+27.5%
0.00%
Q3 2018$598,00027,0680.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders